In summary, this study indicated that TSWN plays an important role in DN treatment, and reduces albuminuria through the regulation of SIRT1/HIF-1α signaling in the podocytes of diabetic mouse kidneys. The gene discussed is HIF1A; the disease is liver dysplastic nodule.